—NIH Begins Oil Spill Health Study “” NIH has launched a 10-year study to examine the potential human health effects of the Deepwater Horizon oil spill in the Gulf of Mexico. Investigators for the Gulf Long-term Follow-up Study (GuLF Study) plan to obtain health information for 55,000 oil spill cleanup workers and volunteers, as well as information about their cleanup work and exposures. They will also monitor participants for health effects, such as respiratory, immunological, and neurobehavioral disorders, over the next 10 years. Samples of blood, urine, toenails, hair, and house dust will be collected from a subset of about 20,000 participants. Those samples will be analyzed for chemicals found in crude oil and dispersants, such as benzene and polycyclic aromatic hydrocarbons. “The goal of the GuLF Study is to help us learn if oil spills and exposure to crude oil and dispersants affect physical and mental health,” says Dale P. Sandler, chief of epidemiology at the National Institute of Environmental Health Sciences and principal investigator of the study. NIH has already committed $19 million to the effort, and the total price tag is expected to climb to $34 million. /articles/89/i10/NIH-Begins-Oil-Spill-Health.html 20110307 Concentrates 89 10 /magazine/89/8910.html NIH Begins Oil Spill Health Study oil spill, health effects con Government & Policy Britt E. Erickson environment Gulf oil spill cleanup workers replace oiled pompons with clean ones on a beach. NOAA NIH Begins Oil Spill Health Study Chemical & Engineering News NIH Begins Oil Spill Health Study NIH Begins Oil Spill Health Study
by Britt E. Erickson | March 07, 2011
—Division of Chemical Health and Safety names 2021 award winners “” The American Chemical Society Division of Chemical Health and Safety (CHAS) has announced its 2021 awards to honor outstanding leadership and service in chemical health and safety. The awards will be presented at the ACS Fall 2021 meeting.
by Linda Wang | April 30, 2021
—Johnson & Johnson launches global health strategy “The firm aims to build scientific capacity while improving access to health care in South Africa” Johnson & Johnson has unveiled a program aimed at improving health care in Africa. Kicking off the initiative with the launch of operations in Cape Town, South Africa, the firm is targeting affordability, drug distribution, and local research capacity.
by Lisa M. Jarvis | April 07, 2016
—Lilly contemplates future of animal health unit “Options for Elanco include sale, spin-off, or retention” Eli Lilly & Co. is mulling the future of its Elanco animal health unit, which is on track to have sales this year of roughly $3 billion. Stock analysts think the unit, which could be spun off, sold, or kept by Lilly, is worth between $12 billion and $15 billion.
by Lisa M. Jarvis | October 30, 2017
—Chemistry influences particulate matter’s health effects “Exposure to particles high in sulfur and metals increased risk of cardiovascular-related hospital admissions” Exposure to fine airborne particles (PM2.5) increases the risk of health problems like heart attacks. Limits on this pollution in many countries account for only the particles’ size, not their composition.
by Katherine Bourzac | October 29, 2021
"We've seen a shift in power," Elanco's Fox says, "from the producers of animal health products to the consumers of animal health products. The customers are bigger and have more purchasing power, but at the same time they depend on suppliers a lot more." The companion animal health sector undoubtedly has been the darling of the animal health industry in the 1990s.
by Ronald S. Rogers | May 31, 1999
—Elanco to buy Bayer’s animal health business for $7.6 billion “Deal will create the second-largest animal health company after Zoetis” Bayer has reached a deal to sell its animal health business to Elanco for $7.6 billion. The transaction will make Elanco the second-largest purveyor of animal health products after Zoetis.
by Marc S. Reisch | August 21, 2019
—Food & Drug Administration Seeks Safety Data On Skin Sanitizers “Disinfectants: Agency to evaluate health care workers’ frequent use of antiseptics” Federal regulators are planning to reevaluate the safety of long-term daily exposure to skin sanitizers, such as hand washes and surgical hand scrubs, used by workers in hospitals and other health care settings. FDA has no data suggesting that active ingredients in health care antiseptics are unsafe or ineffective. But the use of these products has skyrocketed since the agency first evaluated them in the 1970s. “Today, health care professionals use antiseptic products much more frequently than they used to, in some cases up to 100 times a day,” says Theresa M.
by Britt E. Erickson | May 11, 2015
—NIH, NASA Partner on Health Research “” Griffin Credit: Johns Hopkins University A memorandum of understanding between NIH and NASA establishes a new partnership of these two agencies to study human health and disease using the International Space Station. "The station provides a unique environment where researchers can explore fundamental questions about human health issues," NIH Director Elias A.
September 17, 2007